Gene · 3802
Papers2,190
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 2,190
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Immune Checkpoint Blockade: A Strategy to Unleash the Potential of Natural Killer Cells in the Anti-Cancer Therapy. | Cancers (Basel) | 2022 | 36291830 | PubTator, text mining | PubMed |
| The Tumor Microenvironment of Medulloblastoma: An Intricate Multicellular Network with Therapeutic Potential. | Cancers (Basel) | 2022 | 36291792 | PubTator, text mining | PubMed |
| CXCL2 acts as a prognostic biomarker and associated with immune infiltrates in stomach adenocarcinoma. | Medicine (Baltimore) | 2022 | 36281171 | PubTator, text mining | PubMed |
| Integrative study reveals the prognostic and immunotherapeutic value of CD274 and PDCD1LG2 in pan-cancer. | Front Genet | 2022 | 36276934 | PubTator, text mining | PubMed |
| TRAT1 overexpression delays cancer progression and is associated with immune infiltration in lung adenocarcinoma. | Front Oncol | 2022 | 36276113 | PubTator, text mining | PubMed |
| Evaluation of tumor microenvironment and biomarkers of immune checkpoint inhibitor response in metastatic renal cell carcinoma. | J Immunother Cancer | 2022 | 36252996 | PubTator, text mining | PubMed |
| miR-aculous new avenues for cancer immunotherapy. | Front Immunol | 2022 | 36248881 | PubTator, text mining | PubMed |
| Single-cell transcriptome profiling reveals the key role of ZNF683 in natural killer cell exhaustion in multiple myeloma. | Clin Transl Med | 2022 | 36245253 | PubTator, text mining | PubMed |
| KIR-HLA gene diversities and susceptibility to lung cancer. | Sci Rep | 2022 | 36241658 | PubTator, text mining | PubMed |
| Strategies for Potentiating NK-Mediated Neuroblastoma Surveillance in Autologous or HLA-Haploidentical Hematopoietic Stem Cell Transplants. | Cancers (Basel) | 2022 | 36230485 | PubTator, text mining | PubMed |
| CD56-negative NK cells: Frequency in peripheral blood, expansion during HIV-1 infection, functional capacity, and KIR expression. | Front Immunol | 2022 | 36211403 | PubTator, text mining | PubMed |
| A novel cuproptosis-related subtypes and gene signature associates with immunophenotype and predicts prognosis accurately in neuroblastoma. | Front Immunol | 2022 | 36211401 | PubTator, text mining | PubMed |
| A whole genome sequencing approach to anterior cruciate ligament rupture-a twin study in two unrelated families. | PLoS One | 2022 | 36201451 | PubTator, text mining | PubMed |
| Immunotherapy approaches for the treatment of diffuse midline gliomas. | Oncoimmunology | 2022 | 36185807 | PubTator, text mining | PubMed |
| Single-cell transcriptome profiling of the human endometrium of patients with recurrent implantation failure. | Theranostics | 2022 | 36185612 | PubTator, text mining | PubMed |
| Treatment-associated remodeling of the pancreatic cancer endothelium at single-cell resolution. | Front Oncol | 2022 | 36185212 | PubTator, text mining | PubMed |
| Identification of orphan ligand-receptor relationships using a cell-based CRISPRa enrichment screening platform. | Elife | 2022 | 36178190 | PubTator, text mining | PubMed |
| KIR-based inhibitory CARs overcome CAR-NK cell trogocytosis-mediated fratricide and tumor escape. | Nat Med | 2022 | 36175679 | PubTator, text mining | PubMed |
| Induced CD45 Proximity Potentiates Natural Killer Cell Receptor Antagonism. | ACS Synth Biol | 2022 | 36169352 | PubTator, text mining | PubMed |
| Generation and proof-of-concept for allogeneic CD123 CAR-Delta One T (DOT) cells in acute myeloid leukemia. | J Immunother Cancer | 2022 | 36162920 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3802/papers?page=16